Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53,205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy.
Li YR, Zhou Y, Yu J, Zhu Y, Lee D, Zhu E, Li Z, Kim YJ, Zhou K, Fang Y, Lyu Z, Chen Y, Tian Y, Huang J, Cen X, Husman T, Cho JM, Hsiai T, Zhou JJ, Wang P, Puliafito BR, Larson SM, Yang L. Li YR, et al. Among authors: yang l. Mol Ther. 2024 Apr 6:S1525-0016(24)00221-1. doi: 10.1016/j.ymthe.2024.04.005. Online ahead of print. Mol Ther. 2024. PMID: 38584391 Free article.
Engineering stem cells for cancer immunotherapy.
Li YR, Zhou Y, Kramer A, Yang L. Li YR, et al. Among authors: yang l. Trends Cancer. 2021 Dec;7(12):1059-1073. doi: 10.1016/j.trecan.2021.08.004. Epub 2021 Sep 1. Trends Cancer. 2021. PMID: 34479851 Review.
Mucosal-associated invariant T cells for cancer immunotherapy.
Li YR, Zhou K, Wilson M, Kramer A, Zhu Y, Dawson N, Yang L. Li YR, et al. Among authors: yang l. Mol Ther. 2023 Mar 1;31(3):631-646. doi: 10.1016/j.ymthe.2022.11.019. Epub 2022 Dec 5. Mol Ther. 2023. PMID: 36463401 Free PMC article. Review.
Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy.
Zhou Y, Li M, Zhou K, Brown J, Tsao T, Cen X, Husman T, Bajpai A, Dunn ZS, Yang L. Zhou Y, et al. Among authors: yang l. Cancers (Basel). 2022 May 1;14(9):2266. doi: 10.3390/cancers14092266. Cancers (Basel). 2022. PMID: 35565395 Free PMC article. Review.
Off-the-Shelf CAR-NK Cells for Cancer Immunotherapy.
Siegler EL, Zhu Y, Wang P, Yang L. Siegler EL, et al. Among authors: yang l. Cell Stem Cell. 2018 Aug 2;23(2):160-161. doi: 10.1016/j.stem.2018.07.007. Cell Stem Cell. 2018. PMID: 30075127 Free article.
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy.
Li YR, Zhou Y, Kim YJ, Zhu Y, Ma F, Yu J, Wang YC, Chen X, Li Z, Zeng S, Wang X, Lee D, Ku J, Tsao T, Hardoy C, Huang J, Cheng D, Montel-Hagen A, Seet CS, Crooks GM, Larson SM, Sasine JP, Wang X, Pellegrini M, Ribas A, Kohn DB, Witte O, Wang P, Yang L. Li YR, et al. Among authors: yang l. Cell Rep Med. 2021 Nov 16;2(11):100449. doi: 10.1016/j.xcrm.2021.100449. eCollection 2021 Nov 16. Cell Rep Med. 2021. PMID: 34841295 Free PMC article.
53,205 results
You have reached the last available page of results. Please see the User Guide for more information.